Novel role for PDEF in epithelial cell migration and invasion
about
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancerFunctional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesisTransforming properties of YAP, a candidate oncogene on the chromosome 11q22 ampliconThree-dimensional cage-like microscaffolds for cell invasion studiesETS-4 is a transcriptional regulator of life span in Caenorhabditis elegansProfiling Y561-dependent and -independent substrates of CSF-1R in epithelial cellsOncogene-like induction of cellular invasion from centrosome amplification.Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.Making sense of cancer genomic data.Requirement of the epithelium-specific Ets transcription factor Spdef for mucous gland cell function in the gastric antrum.SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.The ETS family of oncogenic transcription factors in solid tumours.Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent MechanismsLPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cellsRelative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancerThe transcription factor SPDEF suppresses prostate tumor metastasisExpression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cellsPDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic targetIntegrative genomic approaches to understanding cancer.ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer.Sustained PKCβII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis.PDEF in prostate cancer.Signatures of prostate-derived Ets factor (PDEF) in cancer.Antimetastatic effects of licochalcone B on human bladder carcinoma T24 by inhibition of matrix metalloproteinases-9 and NF-кB activity.Prostate-derived Ets factor, an oncogenic driver in breast cancer.PON-P: integrated predictor for pathogenicity of missense variants.Outgrowth of single oncogene-expressing cells from suppressive epithelial environments.Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells.Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium.Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.Gene signature driving invasive mucinous adenocarcinoma of the lung.Effects of major human antiprotease alpha-1-antitrypsin on the motility and proliferation of stromal cells from human exfoliated deciduous teeth.Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers.
P2860
Q24306191-60D32408-62C9-4235-87DF-857AA0C844C9Q24681265-036F6DB6-3D55-46FE-999A-8CC0053A5E1BQ24682018-F00A1ED7-1D04-4FB5-B570-A5A6A078CEF3Q27308981-4CC6C343-CBE2-42A3-913F-D1604D674B9DQ27346260-7F7979ED-79D4-4939-A546-9E1C8062307CQ28748716-19FFCF9B-081F-4734-9E6D-F80A72D32B98Q30580976-77B9A56E-D660-4684-9972-55C2D8FA73C2Q33652494-C57EB77B-A7D2-4F78-A18A-B70411357C51Q33681985-4A7FA0F8-3023-42D3-8165-65A8D5921283Q33846850-2050D854-F33C-406C-BAB3-8C45E29BF04EQ34251439-78C280E1-9096-4FEA-A709-DBB32599465FQ34257025-1016C43B-1712-4170-A272-823A180A9F8BQ34555986-8CCE89D9-5473-447C-BF4D-F63CBC183A6DQ35034883-BB0BFFB5-5733-49FB-BA87-5C4722E63EBEQ35046383-699DE687-5885-4140-A296-058BF227712EQ35758944-0162C521-35C3-4EA0-96DB-8ED592C5465AQ36088622-861D053A-6AD5-4E7D-9E1A-F2ECA6FFF435Q36215965-05D8367B-4A76-49D0-B6E7-E342F2B4864FQ36238784-0DB3429F-DE51-4A90-B274-9DEC2D93DF6AQ36667053-F57A9C7A-F875-4719-919E-A95FDD988782Q36995691-A802D73D-C4B7-4648-A138-094F7D173C72Q37011750-F02C063B-4E58-4003-8694-B6E3E7F86121Q37038409-DF71A7E1-43E9-4952-9B1B-1DB2D1B4CA65Q37207654-019A1C54-44DC-4AFD-A865-F058BB1E2A26Q37216672-D8685DAA-19CA-43EE-AA78-8D3D30352C80Q37355527-E5BA1121-C5EF-45C1-B3A5-85A945F3CD62Q37405255-E52BE9B0-1DB8-482A-9B9C-9BE55F9359B6Q37707464-8F83DE51-A762-4F83-83DB-3436258972EFQ37907174-B13D26D0-8924-4CE7-8F25-FAFFEEAE60D3Q38747388-84C34694-05CD-4522-B7AF-7652F5F5A00DQ38968280-5E41FE4A-1D3D-4810-9C25-AEB4ED5948ABQ39281243-3EE741B3-9815-4626-A7F9-F0CE13AD4F17Q39364474-F9EDB8F1-8764-42AD-AE61-FEE72E826DE6Q39399468-2D30983A-C1FB-413B-9FED-C69DF5225DC3Q39633737-91DB2B67-8AC5-4152-AD86-03E552DF232DQ39648518-D9A7857A-0AA2-401A-BD08-1C2755046CD4Q39692770-1E1EBAFE-A2C2-482E-A188-3C639C9FB224Q42293061-F9EC04BB-A551-4283-8B35-1BD097DA0EABQ42969657-F41CA2D6-6A98-4C41-A4B8-CF9E999AFBF7Q47220626-B34A3B31-1BBC-42A3-8427-A81071722DFD
P2860
Novel role for PDEF in epithelial cell migration and invasion
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Novel role for PDEF in epithelial cell migration and invasion
@ast
Novel role for PDEF in epithelial cell migration and invasion
@en
Novel role for PDEF in epithelial cell migration and invasion
@nl
type
label
Novel role for PDEF in epithelial cell migration and invasion
@ast
Novel role for PDEF in epithelial cell migration and invasion
@en
Novel role for PDEF in epithelial cell migration and invasion
@nl
prefLabel
Novel role for PDEF in epithelial cell migration and invasion
@ast
Novel role for PDEF in epithelial cell migration and invasion
@en
Novel role for PDEF in epithelial cell migration and invasion
@nl
P2093
P2860
P1433
P1476
Novel role for PDEF in epithelial cell migration and invasion
@en
P2093
Carolyn N Wrobel
Dennis C Sgroi
Eugene Koh
Joan S Brugge
Ruwanthi N Gunawardane
P2860
P304
P356
10.1158/0008-5472.CAN-05-1196
P407
P577
2005-12-15T00:00:00Z